Ables Iannone Moore & Associates Inc. Invests $168,000 in Aflac Incorporated (NYSE:AFL)

Ables Iannone Moore & Associates Inc. bought a new stake in shares of Aflac Incorporated (NYSE:AFLFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,040 shares of the financial services provider’s stock, valued at approximately $168,000.

Several other institutional investors also recently added to or reduced their stakes in the stock. Norges Bank purchased a new stake in Aflac in the fourth quarter worth about $197,820,000. Morgan Stanley increased its holdings in Aflac by 9.0% during the third quarter. Morgan Stanley now owns 9,643,531 shares of the financial services provider’s stock valued at $740,141,000 after buying an additional 794,784 shares during the period. QRG Capital Management Inc. bought a new position in Aflac in the third quarter worth approximately $47,492,000. Vanguard Group Inc. boosted its position in Aflac by 1.1% during the third quarter. Vanguard Group Inc. now owns 54,208,007 shares of the financial services provider’s stock valued at $4,160,465,000 after purchasing an additional 605,210 shares in the last quarter. Finally, International Assets Investment Management LLC grew its stake in Aflac by 8,861.1% in the fourth quarter. International Assets Investment Management LLC now owns 449,849 shares of the financial services provider’s stock valued at $37,113,000 after purchasing an additional 444,829 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on AFL. Piper Sandler raised their target price on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Truist Financial boosted their target price on Aflac from $80.00 to $82.00 and gave the stock a “hold” rating in a research note on Friday, May 3rd. Wells Fargo & Company raised their price target on Aflac from $81.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, May 10th. Keefe, Bruyette & Woods upped their price objective on shares of Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a report on Wednesday, April 10th. Finally, StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Friday, May 3rd. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Aflac currently has a consensus rating of “Hold” and an average target price of $82.38.

Get Our Latest Report on Aflac

Insider Transactions at Aflac

In related news, Director Charles D. Lake II sold 22,378 shares of Aflac stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total value of $1,957,403.66. Following the sale, the director now owns 61,522 shares of the company’s stock, valued at approximately $5,381,329.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Aflac news, Director Charles D. Lake II sold 22,378 shares of the stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the completion of the transaction, the director now owns 61,522 shares of the company’s stock, valued at $5,381,329.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 600 shares of Aflac stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $84.84, for a total value of $50,904.00. Following the completion of the sale, the director now directly owns 27,550 shares in the company, valued at $2,337,342. The disclosure for this sale can be found here. Insiders have sold a total of 27,978 shares of company stock valued at $2,431,408 in the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

Aflac Stock Performance

NYSE AFL traded up $0.92 on Monday, reaching $87.96. 2,632,625 shares of the company’s stock traded hands, compared to its average volume of 2,211,525. The stock has a 50 day moving average price of $85.49 and a 200-day moving average price of $83.36. The firm has a market cap of $49.98 billion, a price-to-earnings ratio of 9.67, a P/E/G ratio of 2.15 and a beta of 0.96. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.08 and a current ratio of 0.08. Aflac Incorporated has a fifty-two week low of $66.58 and a fifty-two week high of $89.91.

Aflac (NYSE:AFLGet Free Report) last issued its earnings results on Monday, May 6th. The financial services provider reported $1.66 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.08. The firm had revenue of $5.44 billion for the quarter, compared to the consensus estimate of $4.09 billion. Aflac had a return on equity of 16.88% and a net margin of 27.67%. The company’s revenue was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.55 earnings per share. Equities research analysts predict that Aflac Incorporated will post 6.46 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 3rd. Investors of record on Wednesday, May 22nd were paid a $0.50 dividend. This is a boost from Aflac’s previous quarterly dividend of $0.42. This represents a $2.00 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Tuesday, May 21st. Aflac’s payout ratio is currently 22.08%.

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.